A Phase III Randomized Double Blind Study of Letrozole Versus Placebo in Women With Primary Breast Cancer Completing Five or More Years of Adjuvant Tamoxifen.
Phase of Trial: Phase III
Latest Information Update: 29 Mar 2016
At a glance
- Drugs Letrozole (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- 03 Aug 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 03 Aug 2011 Planned end date (Dec 2010) added as reported by ClinicalTrials.gov (parent trial: NCT00003140).
- 03 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (parent trial: NCT00003140).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History